Notch is a membrane receptor that regulates cell proliferation, differentiation and developmental fate switching in a range of tissues, and participates in physiological and pathological processes. Notch protein is activated by brain ischemia and hypoxia in stroke. Four prominent pathways have been identified, namely NF-κB, p53, HIF-1α, and Pin1. In addition, Notch has many other roles in stroke, such as neurogenesis, nerve cell regulation, and inflammatory processes. Ace Therapeutics provides a series of services to explore the role of Notch in stroke.
The notch signaling pathway is involved in the regulation of cell survival and death. In the pathological process of stroke, Notch mediates mastermind-like (MAML), HATp300, Hairy-Enhancer of Split (HES), HES-related protein (HERP), and other proteins to regulate the process of cell death. Given the important role of Notch, Ace Therapeutics provides comprehensive services to explore the Notch-mediated cell death process in the pathological process of stroke.
Studies have shown that the Notch / NF-κB / p53 / HIF-1α axis is involved in the regulation of stroke pathological processes, such as cell stress response, neuronal adaptive response to bioenergetic challenges, and the promotion of neuronal survival during recovery and remodeling phases after ischemic stroke. Ace Therapeutics provides comprehensive services to explore the role of the Notch / NF-κB / p53 / HIF-1α axis in the pathological process of stroke.
You are free to customize the testing services you need or let our professional scientists optimize and implement the complete experimental methods for you. If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.